240 related articles for article (PubMed ID: 26195202)
1. Covert Hepatic Encephalopathy: Who Should Be Tested and Treated?
Flamm SL
Clin Liver Dis; 2015 Aug; 19(3):473-85. PubMed ID: 26195202
[TBL] [Abstract][Full Text] [Related]
2. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
Schulz C; Schütte K; Kropf S; Schmitt FC; Vasapolli R; Kliegis LM; Riegger A; Malfertheiner P
Trials; 2016 Feb; 17(1):111. PubMed ID: 26926775
[TBL] [Abstract][Full Text] [Related]
3. Should We Treat Minimal/Covert Hepatic Encephalopathy, and with What?
Henderson PK; Herrera JL
Clin Liver Dis; 2015 Aug; 19(3):487-95. PubMed ID: 26195203
[TBL] [Abstract][Full Text] [Related]
4. Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis.
Prakash RK; Kanna S; Mullen KD
Clin Ther; 2013 Sep; 35(9):1458-73. PubMed ID: 23972578
[TBL] [Abstract][Full Text] [Related]
5. Rifaximin for the treatment of hepatic encephalopathy.
Lawrence KR; Klee JA
Pharmacotherapy; 2008 Aug; 28(8):1019-32. PubMed ID: 18657018
[TBL] [Abstract][Full Text] [Related]
6. Minimal hepatic encephalopathy: A review.
Nardone R; Taylor AC; Höller Y; Brigo F; Lochner P; Trinka E
Neurosci Res; 2016 Oct; 111():1-12. PubMed ID: 27153746
[TBL] [Abstract][Full Text] [Related]
7. Hepatic encephalopathy: how to test and treat.
Rahimi RS; Rockey DC
Curr Opin Gastroenterol; 2014 May; 30(3):265-71. PubMed ID: 24717765
[TBL] [Abstract][Full Text] [Related]
8. Performance of EncephalApp Stroop Test in Cirrhotic Patients for Evaluating Covert Hepatic Encephalopathy.
Kurniawan J; Ranty SS; Sulaiman AS; Gani RA
Acta Med Indones; 2023 Jul; 55(3):296-306. PubMed ID: 37915156
[TBL] [Abstract][Full Text] [Related]
9. Review article: the modern management of hepatic encephalopathy.
Bajaj JS
Aliment Pharmacol Ther; 2010 Mar; 31(5):537-47. PubMed ID: 20002027
[TBL] [Abstract][Full Text] [Related]
10. Minimal hepatic encephalopathy.
Stinton LM; Jayakumar S
Can J Gastroenterol; 2013 Oct; 27(10):572-4. PubMed ID: 24106728
[TBL] [Abstract][Full Text] [Related]
11. [Rifaximin in the treatment of hepatic encephalopathy].
Lata J; Hůlek P; Fejfar T; Spicák J; Drastich P; Marecek Z; Brůha R; Husová L; Senkyrík M
Vnitr Lek; 2002 Jun; 48(6):578-82. PubMed ID: 12132365
[TBL] [Abstract][Full Text] [Related]
12. Rifaximin and nonabsorbable disaccharides for hepatic encephalopathy.
Guslandi M; Cella A
Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):376. PubMed ID: 20134260
[No Abstract] [Full Text] [Related]
13. [Hepatic encephalopathy: recent developments].
Deltenre P; Moradpour D
Rev Med Suisse; 2014 Sep; 10(440):1612, 1614-6. PubMed ID: 25277000
[TBL] [Abstract][Full Text] [Related]
14. Optimal treatment of hepatic encephalopathy.
Waghray A; Waghray N; Kanna S; Mullen K
Minerva Gastroenterol Dietol; 2014 Mar; 60(1):55-70. PubMed ID: 24632768
[TBL] [Abstract][Full Text] [Related]
15. Rifaximin is an efficacious treatment for the Parkinsonian phenotype of hepatic encephalopathy.
Kok B; Foxton MR; Clough C; Shawcross DL
Hepatology; 2013 Oct; 58(4):1516-7. PubMed ID: 23471844
[No Abstract] [Full Text] [Related]
16. Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis.
Jiang Q; Jiang XH; Zheng MH; Jiang LM; Chen YP; Wang L
Eur J Gastroenterol Hepatol; 2008 Nov; 20(11):1064-70. PubMed ID: 19047837
[TBL] [Abstract][Full Text] [Related]
17. Management of Hepatic Encephalopathy: A Primer.
Jawaro T; Yang A; Dixit D; Bridgeman MB
Ann Pharmacother; 2016 Jul; 50(7):569-77. PubMed ID: 27126547
[TBL] [Abstract][Full Text] [Related]
18. Rifaximin: an alternative for the treatment of hepatic encephalopathy.
Rigali VT
Conn Med; 2006 Sep; 70(8):499-501. PubMed ID: 17089807
[No Abstract] [Full Text] [Related]
19. Effect of rifaximin, probiotics, and l-ornithine l-aspartate on minimal hepatic encephalopathy: a randomized controlled trial.
Sharma K; Pant S; Misra S; Dwivedi M; Misra A; Narang S; Tewari R; Bhadoria AS
Saudi J Gastroenterol; 2014; 20(4):225-32. PubMed ID: 25038208
[TBL] [Abstract][Full Text] [Related]
20. Quality of life in patients with minimal hepatic encephalopathy.
Ridola L; Nardelli S; Gioia S; Riggio O
World J Gastroenterol; 2018 Dec; 24(48):5446-5453. PubMed ID: 30622374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
